# K081779: GOLOX-93

- Pathway: 510(k) (Traditional)
- Applicant: Respironics, Inc.
- Decided: Sep 19, 2008 after 88 days
- Product code: BYJ (Unit, Liquid-Oxygen, Portable)
- Device class: 2
- Regulation: 21 CFR 868.5655
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K933930 (1994). 4 ancestors in all.
No later device cites it as a predicate yet.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K072723: Respironics Golox, Respironics, Inc. (2008) Summary page 1.

## Cited in the summary but kept off the family tree
- K0501153: Caire Spirit Model HAS. Number could not be read

## Indications for use
The GoLox -93 is intended to provide supplemental oxygen to patients who have difficulty extracting oxygen from the air that they breathe. The patients would normally receive oxygen via a nasal cannula. It is intended for ambulatory use inside and outside of the home. It is not intended to be life supporting or life sustaining. The device has no contraindications.

Source page: https://510kreport.com/device/K081779
Methodology: https://510kreport.com/methodology